General Injectables & Vaccines Inc is categorized under Drug Brokers in Bastian, VA and active since 1999.
General Injectables & Vaccines Inc was established in 1999, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Stanley Bergman at the company’s headquarters by writing to 80 Summit View Lane, Bastian, Virginia VA 24314 or by phoning (276) 688-4121. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | General Injectables & Vaccines Inc |
| Contact Person: | Stanley Bergman |
| Address: | 80 Summit View Lane, Bastian, Virginia 24314 |
| Phone Number: | (276) 688-4121 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 1999 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
General Injectables & Vaccines Inc was started in 1999 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Stanley Bergman for inquiries that concern General Injectables & Vaccines Inc by calling the company number (276) 688-4121, as your correspondence is most welcome. Additionally, the physical location of the headquarters of General Injectables & Vaccines Inc can be found at the coordinates 37.155686,-81.151012 as well as the street address 80 Summit View Lane in Bastian, Virginia 24314.
For its online presence, you may visit General Injectables & Vaccines Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.